Published in Arch Intern Med on May 23, 2005
Types of unintended consequences related to computerized provider order entry. J Am Med Inform Assoc (2006) 7.86
Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc (2006) 6.39
The technology acceptance model: its past and its future in health care. J Biomed Inform (2009) 5.37
The extent and importance of unintended consequences related to computerized provider order entry. J Am Med Inform Assoc (2007) 3.92
Some unintended consequences of clinical decision support systems. AMIA Annu Symp Proc (2007) 2.87
Health information technology: fallacies and sober realities. J Am Med Inform Assoc (2010) 2.85
Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol (2012) 2.67
Prescription errors and outcomes related to inconsistent information transmitted through computerized order entry: a prospective study. Arch Intern Med (2009) 2.45
Just what the doctor ordered. Review of the evidence of the impact of computerized physician order entry system on medication errors. Health Serv Res (2008) 2.05
The unintended consequences of computerized provider order entry: findings from a mixed methods exploration. Int J Med Inform (2008) 1.93
EHR safety: the way forward to safe and effective systems. J Am Med Inform Assoc (2008) 1.90
Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med (2010) 1.88
An analysis of computer-related patient safety incidents to inform the development of a classification. J Am Med Inform Assoc (2010) 1.74
A review on systematic reviews of health information system studies. J Am Med Inform Assoc (2010) 1.69
Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial. Crit Care (2006) 1.60
An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies. J Am Med Inform Assoc (2010) 1.36
Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc (2011) 1.30
Legal, ethical, and financial dilemmas in electronic health record adoption and use. Pediatrics (2011) 1.29
A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. J Am Med Inform Assoc (2007) 1.29
Effect of computerisation on the quality and safety of chemotherapy prescription. Qual Saf Health Care (2006) 1.21
Qualitative evaluation of an electronic prescribing and administration system. Qual Saf Health Care (2007) 1.19
Clinical decision support: progress and opportunities. J Am Med Inform Assoc (2010) 1.17
Assessing the anticipated consequences of Computer-based Provider Order Entry at three community hospitals using an open-ended, semi-structured survey instrument. Int J Med Inform (2007) 1.08
What stands in the way of technology-mediated patient safety improvements?: a study of facilitators and barriers to physicians' use of electronic health records. J Patient Saf (2011) 1.05
Implementation pearls from a new guidebook on improving medication use and outcomes with clinical decision support. Effective CDS is essential for addressing healthcare performance improvement imperatives. J Healthc Inf Manag (2009) 1.01
Understanding pharmacist decision making for adverse drug event (ADE) detection. J Eval Clin Pract (2009) 1.00
Value of human factors to medication and patient safety in the intensive care unit. Crit Care Med (2010) 1.00
Creating resilient IT: how the sign-out sheet shows clinicians make healthcare work. AMIA Annu Symp Proc (2006) 0.96
Organization-wide adoption of computerized provider order entry systems: a study based on diffusion of innovations theory. BMC Med Inform Decis Mak (2009) 0.95
Prescribers' expectations and barriers to electronic prescribing of controlled substances. J Am Med Inform Assoc (2011) 0.94
Overview of medical errors and adverse events. Ann Intensive Care (2012) 0.94
Medication safety and knowledge-based functions: a stepwise approach against information overload. Br J Clin Pharmacol (2013) 0.94
Impact of computerized physician order entry (CPOE) system on the outcome of critically ill adult patients: a before-after study. BMC Med Inform Decis Mak (2011) 0.89
Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol (2012) 0.89
Computerized surveillance for adverse drug events in a pediatric hospital. J Am Med Inform Assoc (2009) 0.88
Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol (2013) 0.86
Chemotherapy prescribing errors: an observational study on the role of information technology and computerized physician order entry systems. BMC Health Serv Res (2013) 0.84
Adverse drug events identified by triggers at a teaching hospital in Brazil. BMC Pharmacol Toxicol (2014) 0.83
Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period. J Am Med Inform Assoc (2011) 0.83
STAT-HI: A socio-technical assessment tool for health informatics implementations. Open Med Inform J (2010) 0.83
Electronic health records and adverse drug events after patient transfer. Qual Saf Health Care (2010) 0.83
Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature. BMC Health Serv Res (2013) 0.82
Effect of a Computerized Provider Order Entry (CPOE) System on medication orders at a community hospital and university hospital. AMIA Annu Symp Proc (2007) 0.80
Using nurses and office staff to report prescribing errors in primary care. Int J Qual Health Care (2008) 0.80
Computerized orders with standardized concentrations decrease dispensing errors of continuous infusion medications for pediatrics. J Pediatr Pharmacol Ther (2010) 0.79
How often do physicians review medication charts on ward rounds? BMC Clin Pharmacol (2008) 0.78
The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population. J Am Med Inform Assoc (2007) 0.78
Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Eur J Clin Pharmacol (2009) 0.78
Computerized physician order entry: promise, perils, and experience. Neurohospitalist (2014) 0.77
Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiol Oncol (2010) 0.77
Debunking health IT usability myths. Appl Clin Inform (2013) 0.76
Value of pharmacist medication interviews on optimizing the electronic medication reconciliation process. Hosp Pharm (2014) 0.76
Exposure to High-Risk Medications is Associated With Worse Outcomes in Older Veterans With Chronic Pain. Am J Med Sci (2015) 0.76
The impact of electronic health record implementation and use on performance of the Surgical Care Improvement Project measures. Health Serv Res (2014) 0.76
Duplicate orders: an unintended consequence of computerized provider/physician order entry (CPOE) implementation: analysis and mitigation strategies. Appl Clin Inform (2012) 0.75
Clinical health information technologies and the role of medicaid. Health Care Financ Rev (2006) 0.75
A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital. Korean J Intern Med (2012) 0.75
Propofol-associated QTc prolongation. Ther Adv Drug Saf (2016) 0.75
Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process. BMC Med Inform Decis Mak (2010) 0.75
The computerized medical record: the next frontier. Arch Intern Med (2006) 0.75
Predictive modeling of structured electronic health records for adverse drug event detection. BMC Med Inform Decis Mak (2015) 0.75
From simply inaccurate to complex and inaccurate: complexity in standards-based quality measures. AMIA Annu Symp Proc (2011) 0.75
Cost-effectiveness of ward-based pharmacy care in surgical patients: protocol of the SUREPILL (Surgery & Pharmacy In Liaison) study. BMC Health Serv Res (2011) 0.75
Computerized order entry and bar-coded medication. Arch Intern Med (2006) 0.75
Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study Proposal. JMIR Res Protoc (2017) 0.75
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol (2006) 11.26
Measuring diagnoses: ICD code accuracy. Health Serv Res (2005) 6.72
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med (2006) 4.01
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol (2007) 3.85
The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol (2002) 3.63
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol (2009) 3.26
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst (2006) 3.23
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg (2009) 3.07
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer (2002) 3.05
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS (2006) 3.02
Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol (2012) 2.67
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA (2007) 2.43
Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol (2004) 2.33
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol (2004) 2.30
Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol (2004) 2.27
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns (2006) 2.18
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol (2009) 2.16
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol (2010) 2.16
Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol (2005) 2.10
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04
Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care (2007) 2.04
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol (2007) 1.91
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke (2004) 1.78
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer (2014) 1.76
Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion (2008) 1.73
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract (2012) 1.63
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA (2006) 1.59
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology (2006) 1.57
Automated identification of adverse events related to central venous catheters. J Biomed Inform (2006) 1.55
Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol (2003) 1.55
Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med (2002) 1.54
Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol (2013) 1.52
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol (2003) 1.50
Czech health two decades on from the Velvet Revolution. Lancet (2009) 1.49
Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect. Ann Intern Med (2002) 1.45
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
Colorectal cancer screening among African-American and white male veterans. Am J Prev Med (2005) 1.39
Future history: medical informatics in geriatrics. J Gerontol A Biol Sci Med Sci (2003) 1.38
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res (2006) 1.36
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med (2007) 1.34
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer (2005) 1.33
Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant (2004) 1.28
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica (2010) 1.27
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol (2005) 1.27
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery (2003) 1.24
Textractor: a hybrid system for medications and reason for their prescription extraction from clinical text documents. J Am Med Inform Assoc (2010) 1.23
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer (2006) 1.19
Document clustering of clinical narratives: a systematic study of clinical sublanguages. AMIA Annu Symp Proc (2011) 1.16
Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis (2005) 1.13
Biomedical text summarization to support genetic database curation: using Semantic MEDLINE to create a secondary database of genetic information. J Med Libr Assoc (2010) 1.13
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol (2008) 1.10
Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg (2005) 1.10
Utah's statewide informatics platform for translational and clinical science. AMIA Annu Symp Proc (2008) 1.07
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Dynamic summarization of bibliographic-based data. BMC Med Inform Decis Mak (2011) 1.06
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int (2011) 1.03
Automatic acquisition of sublanguage semantic schema: towards the word sense disambiguation of clinical narratives. AMIA Annu Symp Proc (2010) 1.02
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int (2013) 1.01
Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm (2007) 1.00
Understanding pharmacist decision making for adverse drug event (ADE) detection. J Eval Clin Pract (2009) 1.00
Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? J Clin Oncol (2009) 1.00
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol (2005) 0.99
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol (2007) 0.99
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.98
Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist (2007) 0.98
Improving mammography screening among the medically underserved. J Gen Intern Med (2013) 0.98
Systematic review of piperacillin-induced neutropenia. Drug Saf (2007) 0.97
A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun (2005) 0.96
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res (2009) 0.96
Erythropoietin, uncertainty principle and cancer related anaemia. BMC Cancer (2002) 0.96
The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol (2007) 0.96
Clinicians' perceptions about use of computerized protocols: a multicenter study. Int J Med Inform (2007) 0.94
Amiodarone-associated optic neuropathy: a critical review. Am J Med (2012) 0.93
Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw (2010) 0.93
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening. J Clin Oncol (2009) 0.93
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol (2004) 0.93
Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract (2007) 0.92
Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Text summarization as a decision support aid. BMC Med Inform Decis Mak (2012) 0.91
The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. Am J Kidney Dis (2005) 0.91
Mining electronic health records: an additional perspective. Nat Rev Genet (2013) 0.91
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol (2004) 0.91
Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer (2004) 0.90
Critical gaps in the world's largest electronic medical record: Ad Hoc nursing narratives and invisible adverse drug events. AMIA Annu Symp Proc (2003) 0.90